Dr. Bellmunt on Immunotherapy Combination Trials in Bladder Cancer – OncLive
OncLive |
Dr. Bellmunt on Immunotherapy Combination Trials in Bladder Cancer
OncLive Joaquim Bellmunt, MD, PhD, associate professor of medicine, Harvard Medical School, director, Bladder Cancer Center, Dana-Farber Cancer Institute, discusses trials investigating combinations with immunotherapy for patients with bladder cancer. There … |
